| 
Results for gilead. Search took 0.25 seconds.
Seen that? - Gilead wrestles with Roche for Tamiflu rights
in The Biotech Weblog, on October 9, 2009
... Gilead wrestles with Roche for Tamiflu rights at The Biotech Weblog The Foster City-based Gilead Sciences, best known for its AIDS drug Viread, not...
Fast Company 评出了2009年度创新企业50强
in Wangtam, on 2009-02-25
作为与《财富》和《商业周刊》齐名的美国最具影响力的商业杂志之一，《Fast Company》近日评出了 2009 年度" 创新企业50强 "，排名首位的是成功将 Barack Obama 推上总统宝座的"奥巴马竞选团队"。
此外，Google 位居第二、Apple 第四，Cisco 第五、Intel 第六、Amazon 第九、HP 十二、Nokia 十三、Facebook 十五、IBM 十九、任天堂二十一、微软三十四。另外，还有两家中国企业上榜，分别是排名第八的无锡药明康德新药开发有限公司和位居第四十五位的比亚迪：
1. 奥巴马竞选团队
2. 谷歌...
Company directors: the million dollar club
in Sox First, on January 24, 2008
... million a year. The Corporate Board Member magazine list includes western union , Hologic, Gilead Sciences, Google, First Community Bancorp, Conseco, Bristol-Myers Squibb and Apple. Are comp...
Letairis™ (ambrisentan), FDA-Approved for Pulmonary Arterial Hypertension
in Straightfromthedoc, on June 17, 2007
... Manufactured by Gilead Sciences, Inc. , Letairis™ (ambrisentan) has recently been approved by the FDA for the treatment of pulmonary arterial hypertension .
Pulmonary arterial hypertensi...
Big Biotech Stocks To Perform Better in 2007
in The Biotech Weblog, on January 12, 2007
...r biotech firms, but analysts say big biotech companies like Amgen , Genentech , Celgene and Gilead Sciences would perform better in 2007.
"We're looking forward to an economy that&#...
Morgan Stanley Expect Favorable Returns from Large Biotech Companies
in The Biotech Weblog, on July 20, 2006
...Latest from the pipeline: Lucentis, against neovascular age-related macular degenetration .
Gilead Sciences : Develops biopharmaceuticals for the treatment of life-threatening infectious diseases ...
FDA Approves Atripla, Once Daily Single Tablet AIDS Drug
in The Biotech Weblog, on July 14, 2006
...-in-one AIDS pill. The drug, called Atripla , was jointly developed by Bristol-Myers Squibb Co and Gilead, Inc, and combines the powers of the commonly prescribed AIDS drugs Sustiva , Viread and ...
Top 20 Molecular Millionaires
in The Biotech Weblog, on May 31, 2006
...300 Million
1. Arthur Levinson, Ph.D., Genentech
Over $250 Million
2. John Martin, Ph.D., Gilead Sciences
$50-100 Million
3. William A. Haseltine, Ph.D., Human Genome Sciences
4. So...
Rumsfeld makes a killing
in Sox First, on March 20, 2006
... report on US Secretary of Defence Donald Rumsfeld making $5 million on it after selling shares in Gilead Sciences, the California biotechnology company that developed the drug. Rumy was on the Gile...
Gilead and Bristol-Myers Squibb Develop Once-A-Day AIDS Pill
in The Biotech Weblog, on January 23, 2006
... More than a year ago, Gilead Sciences and Bristol -Myers Squibb entered into a joint venture to develop and commercialize a once-daily fixed-dose combination of drugs against AIDS . Last wee...
Gilead wrestles with Roche for Tamiflu rights
in The Biotech Weblog, on July 9, 2005
...
The Foster City-based Gilead Sciences, best known for its AIDS drug Viread, notified Swiss pharmaceutical giant Roche on Thursday that it was terminating the 1996 agreement that gave the Swiss...